Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity namePARADIGM BIOPHARMACEUTICALS LIMITED..Announcement TypeNew announcementDate of this announcementMonday September 14, 2026The +securities to be quoted...
Application for quotation of securities - PAR
Filed with ASX ·
6ix hasn’t read this filing yet.
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Notice under Section 708A
- Notification regarding unquoted securities - PAR
- Drawdown of Tranche 4 under the Convertible Note Facility
- Melbourne Investor Lunch
- Appendix 4E and 2026 Annual Report
Later from Paradigm Biopharmaceuticals
- Dr Daniel Furtner appointed Chief Medical Officer
- Trading Halt
- Suspension from Quotation
- Phase 3 Interim Result Below Continuation Threshold
- Notification of cessation of securities - PAR
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals